You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

List of Excipients in API moxifloxacin hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing moxifloxacin hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Alcon Laboratories Inc MOXEZA moxifloxacin hydrochloride 0065-0006 BORIC ACID
Alcon Laboratories Inc MOXEZA moxifloxacin hydrochloride 0065-0006 HYDROCHLORIC ACID
Alcon Laboratories Inc MOXEZA moxifloxacin hydrochloride 0065-0006 SODIUM CHLORIDE
Alcon Laboratories Inc MOXEZA moxifloxacin hydrochloride 0065-0006 SODIUM HYDROXIDE
Alcon Laboratories Inc MOXEZA moxifloxacin hydrochloride 0065-0006 SORBITOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing moxifloxacin hydrochloride

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc moxifloxacin hydrochloride 0093-7387 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc moxifloxacin hydrochloride 0093-7387 CROSCARMELLOSE SODIUM
Teva Pharmaceuticals USA Inc moxifloxacin hydrochloride 0093-7387 FERRIC OXIDE RED
Teva Pharmaceuticals USA Inc moxifloxacin hydrochloride 0093-7387 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc moxifloxacin hydrochloride 0093-7387 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for moxifloxacin hydrochloride

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BORIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

moxifloxacin hydrochloride drug variants containing POLYETHYLENE GLYCOL 400

Company Ingredient NDC
Teva Pharmaceuticals USA Inc moxifloxacin hydrochloride 0093-7387
Torrent Pharmaceuticals Limited moxifloxacin hydrochloride 13668-201
Novel Laboratories Inc moxifloxacin hydrochloride 40032-034
MSN LABORATORIES PRIVATE LIMITED moxifloxacin hydrochloride tablets, 400 mg 69539-006
Novadoz Pharmaceuticals LLC moxifloxacin hydrochloride tablets, 400 mg 72205-001
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

moxifloxacin hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Alcon Laboratories Inc moxifloxacin hydrochloride 0065-0006
Novartis Pharmaceuticals Corporation moxifloxacin hydrochloride 0078-0939
Teva Pharmaceuticals USA Inc moxifloxacin hydrochloride 0093-7387
Sandoz Inc moxifloxacin hydrochloride 0781-7135
Upsher-Smith Laboratories LLC moxifloxacin hydrochloride 0832-1410
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM SULFATE

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: SULFURIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TYLOXAPOL

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group